283165-99-1 Usage
Uses
Used in Pharmaceutical Research:
[(S)-3-chloro-1-(4-nitro-benzyl)-2-oxo-propyl]-carbamic acid tert-butyl ester is used as a building block for the development of new pharmaceutical compounds due to its unique structural features and chiral configuration. Its ability to modulate biological activity makes it a valuable asset in the creation of novel drugs with specific therapeutic targets.
Used in Organic Synthesis:
In the field of organic synthesis, [(S)-3-chloro-1-(4-nitro-benzyl)-2-oxo-propyl]-carbamic acid tert-butyl ester serves as an important intermediate for the synthesis of complex organic molecules. Its versatile functional groups allow for further chemical modifications and the formation of a wide range of compounds with diverse applications.
Used in Chemical Modifiers:
This carbamic acid derivative is also used as a chemical modifier to enhance the properties of various materials. Its structural features can be exploited to improve the performance of materials in different industries, such as enhancing the stability or reactivity of catalysts, or modifying the properties of polymers for specific applications.
Used in Analytical Chemistry:
[(S)-3-chloro-1-(4-nitro-benzyl)-2-oxo-propyl]-carbamic acid tert-butyl ester can be employed as a chiral reference compound in analytical chemistry. Its distinct (S) configuration makes it useful for studying enantioselective reactions and understanding the stereochemistry of various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 283165-99-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,3,1,6 and 5 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 283165-99:
(8*2)+(7*8)+(6*3)+(5*1)+(4*6)+(3*5)+(2*9)+(1*9)=161
161 % 10 = 1
So 283165-99-1 is a valid CAS Registry Number.
283165-99-1Relevant academic research and scientific papers
2-HYDROXY-1,3-DIAMINOPROPANE DERIVATIVES
-
Page/Page column 13; 14, (2008/12/05)
The invention relates to novel cyclic compounds of the formula (I), in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments comprising them.
